| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |